Precursor Cell Lymphoblastic Leukemia-Lymphoma: all 2,121 studies
Page 15 of 22. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- Genetic Study of Familial Acute Lymphoblastic LeukemiaCompletedNCT03067584
- Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMTWithdrawnNCT03066466Phase 3
- Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)Status unknownNCT03035344
- CART-19 Cells For MRD Positive CD19+ ALLStatus unknownNCT03027739Phase 2/3
- Optimizing 6-mercaptopurine Therapy in Pediatric Acute Lymphoblastic Leukemia by Using AllopurinolStatus unknownNCT03022747Phase 2
- Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and AdolescentsActive, not recruitingNCT03020030Phase 3
- A Phase I Study Evaluating Safety and Efficacy of C-CAR011 Treatment in Adult Subjects With r/r CD19+B-ALLStatus unknownNCT03018093Phase 1
- Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALLActive, not recruitingNCT03016377Phase 1
- Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaActive, not recruitingNCT03007147Phase 3
- Home-exercise Program for Children and Adolescent Survivors of Acute Lymphoblastic LeukemiaCompletedNCT03005392Phase 1/2
- Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse RiskStatus unknownNCT03000335
- Haploidentical BMT With Post-Transplant Cyclophosphamide and BendamustineCompletedNCT02996773Phase 1
- Design and Evaluation of Care Environment and Technology at Pediatric RadiotherapyCompletedNCT02993978
- CD19 CAR T Cells in Patients With Resistant or Refractory CD19+ Acute Lymphoblastic LeukemiaCompletedNCT02975687Phase 1
- A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic LeukemiaWithdrawnNCT02973191Phase 1/2
- A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell LeukemiaStatus unknownNCT02968472Phase 1
- CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell MalignanciesStatus unknownNCT02965092Phase 1/2
- Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesCompletedNCT02960646Phase 1
- The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and AdolescentsCompletedNCT02953730Phase 4
- ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell TumorsStatus unknownNCT02938741Phase 4
- G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant TumorStatus unknownNCT02933333Phase 4
- The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL).Status unknownNCT02924753Phase 1
- Low-Dose Daunorubicin in Relapsed/Refractory Acute LeukemiaCompletedNCT02914977Phase 1
- Thiopurine EnhAnced Maintenance TherapyCompletedNCT02912676Phase 1/2
- Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release SyndromeCompletedNCT02906371Phase 1
- Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 StudyStatus unknownNCT02894645Phase 4
- PCAR-119 Bridge Immunotherapy Prior to Stem Cell Transplant in Treating Patients With CD19 Positive Leukemia and LymphomaStatus unknownNCT02892695Phase 1/2
- Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803CompletedNCT02890758Phase 1
- Dasatinib and Low Intensity Chemotherapy for Ph+ Acute Lymphoblastic LeukemiaCompletedNCT02888990Phase 2
- Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALLStatus unknownNCT02888977
- Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified TreatmentCompletedNCT02881086Phase 3
- Role of the Microparticles and of Tissue Factor in the Pro-thrombotic Phenotype and the Thromboembolic Complications During the Acute Lymphoblastic Leukemia in Children.CompletedNCT02862652Not applicable
- Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell TransplantActive, not recruitingNCT02861417Phase 2
- Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaWithdrawnNCT02861040Phase 1
- Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and LymphomaStatus unknownNCT02851589Phase 1/2
- Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric OncologyCompletedNCT02847130
- LBL-2016 for Children or Adolescents in ChinaActive, not recruitingNCT02845882Phase 3
- CAR-T Cell Immunotherapy in CD19 Positive Relapsed or Refractory Leukemia and LymphomaStatus unknownNCT02819583Phase 1/2
- Study of Pts With Philadelphia Chromosome-Pos ALL With Comb of Ibrutinib, Dasatinib, and PrednisoneWithdrawnNCT02815059Phase 1
- Long-Term Follow-up Study for Patients Previously Treated With JCAR015CompletedNCT02813252
- Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic LeukemiaStatus unknownNCT02810223Phase 1
- Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic LeukemiaCompletedNCT02808442Phase 1
- GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory LeukemiaCompletedNCT02799147Phase 1/2
- Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous LeukemiaTerminatedNCT02795520Phase 1/2
- Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior TransplantationActive, not recruitingNCT02790515Phase 2
- An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the USCompletedNCT02783651
- Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic LeukemiaCompletedNCT02779283Phase 1
- Ponatinib With Chemotherapy for Young Adults Ph Positive Acute Lymphoblastic LeukemiaStatus unknownNCT02776605Phase 2
- T-cells Expressing Anti-CD19 CAR in Pediatric and Young Adults With B-cell MalignanciesStatus unknownNCT02772198Phase 1/2
- Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALLStatus unknownNCT02766868Phase 2
- StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme MalignanciesWithdrawnNCT02765997Phase 2
- Haploidentical Hematopoietic Stem Cell Transplantation for Acute LeukemiasStatus unknownNCT02759822
- Azacitidine in Haploidentical Donor Hematopoietic Cell TransplantationTerminatedNCT02750254Phase 1
- Dose Escalation Study of UCART19 in Adult Patients With Relapsed / Refractory B-cell Acute Lymphoblastic LeukaemiaCompletedNCT02746952Phase 1
- D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic LeukemiaStatus unknownNCT02744768Phase 2
- PH 1 Study to Evaluate Safety and Tolerability of XmAb14045 in Patients With CD123-expressing Hematologic MalignanciesCompletedNCT02730312Phase 1
- Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCTTerminatedNCT02728700Phase 1
- A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and AdolescentsActive, not recruitingNCT02716233Phase 3
- Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia PatientsStatus unknownNCT02690922Phase 4
- Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/LymphomaStatus unknownNCT02685670Phase 1/2
- BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCTCompletedNCT02670252Phase 3
- Allo HSCT Using RIC for Hematological DiseasesCompletedNCT02661035Phase 2
- Modified MRCUKALLⅫ/ECOGE2993 Regimen for ALLStatus unknownNCT02660762Phase 2
- Salvia Hispanica Seed in Reducing Risk of Disease Recurrence in Patients With Non-Hodgkin LymphomaCompletedNCT02652715Not applicable
- Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or OlderWithdrawnNCT02647190Phase 1
- Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot StudyWithdrawnNCT02632903Phase 2
- Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic LeukemiaTerminatedNCT02618109Phase 4
- Chemo Sensitization Before Hematopoietic Stem Cell Transplantation in Patients With Acute Leukemia in Complete RemissionStatus unknownNCT02605460Phase 2
- Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic LeukemiaTerminatedNCT02588456Phase 1
- Acute Lymphoblastic Leukemia Therapies Informed by Genomic AnalysesTerminatedNCT02580981Not applicable
- Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)WithdrawnNCT02578511Phase 1
- Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic MalignanciesCompletedNCT02566395Phase 3
- Clofarabine in Chinese Pediatric Patients With Refractory or Relapsed Acute Lymphoblastic LeukemiaCompletedNCT02544789Phase 2
- Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic LeukemiaCompletedNCT02544438Phase 1/2
- Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWithdrawnNCT02538926Phase 2
- CD19-Specific T-cells in Treating Patients With Advanced Lymphoid MalignanciesCompletedNCT02529813Phase 1
- Dasatinib Combined With Chemotherapy in Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaCompletedNCT02523976Phase 2
- Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or OlderActive, not recruitingNCT02494882Phase 1
- Administration of Donor MultiTAA-Specific T Cells for ALLCompletedNCT02475707Phase 1
- Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell MalignanciesStatus unknownNCT02456350Phase 1
- A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell MalignanciesTerminatedNCT02454270Phase 1
- Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During InductionStatus unknownNCT02451774Phase 2/3
- Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute LeukemiaCompletedNCT02446964Phase 1
- iCare for Cancer PatientsTerminatedNCT02435550Not applicable
- Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia (2015)TerminatedNCT02428517
- The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy RegimensStatus unknownNCT02413021Phase 1
- ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic SyndromeTerminatedNCT02392572Phase 1/2
- Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic LeukemiaCompletedNCT02388048Phase 2
- Pilot Study of Redirected Autologous T Cells Engineered to Contain Humanized Anti-CD19 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma Previously Treated With Cell TherapyCompletedNCT02374333Phase 1
- Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic LeukemiaCompletedNCT02373579Phase 2
- Let's Play! Healthy Kids After CancerCompletedNCT02361047Not applicable
- Vincristine PK and PD in the AYA Population Compared to Younger ChildrenStatus unknownNCT02360930
- Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute LeukemiaStatus unknownNCT02345915Not applicable
- A Pilot RCT of the PRISM Intervention for AYAs With CancerCompletedNCT02340884Phase 2
- Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in ChildrenStatus unknownNCT02339350Phase 2
- Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic MalignanciesStatus unknownNCT02338479
- Moxetumomab Pasudotox (CAT-8015, HA22) in Children With B-lineage Acute Lymphoblastic Leukemia and Minimal Residual Disease Prior to Allogeneic Hematopoietic Stem Cell TransplantationTerminatedNCT02338050Phase 2
- Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell TransplantSuspendedNCT02333162Phase 1
- Treosulfan-based Conditioning in Paediatric Patients With Haematological MalignanciesCompletedNCT02333058Phase 2
- A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation (FA5-Bucy) in Treating Patients With High-risk, Recurrent or Refractory Acute Leukemia and Advanced Myelodysplastic SyndromeStatus unknownNCT02328950